Mustang Bio, Inc. (MBIO): Price and Financial Metrics

Mustang Bio, Inc. (MBIO): $0.27

0.01 (-4.61%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add MBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#115 of 339

in industry

MBIO Price/Volume Stats

Current price $0.27 52-week high $1.97
Prev. close $0.28 52-week low $0.13
Day low $0.26 Volume 702,500
Day high $0.29 Avg. volume 9,478,645
50-day MA $0.26 Dividend yield N/A
200-day MA $0.56 Market Cap 9.94M

MBIO Stock Price Chart Interactive Chart >


Mustang Bio, Inc. (MBIO) Company Bio


Mustang Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engineered T cell technology. Its lead programs include MB-101 for the treatment of brain cancer that is in Phase I trials; and MB-102, a therapeutic agent in acute myeloid leukemia, which is in Phase I trials. The company was founded in 2015 and is based in New York, New York. Mustang Bio Inc. is a subsidiary of Fortress Biotech, Inc.


MBIO Latest News Stream


Event/Time News Detail
Loading, please wait...

MBIO Latest Social Stream


Loading social stream, please wait...

View Full MBIO Social Stream

MBIO Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching MBIO

Want to see what other sources are saying about Mustang Bio Inc's financials and stock price? Try the links below:

Mustang Bio Inc (MBIO) Stock Price | Nasdaq
Mustang Bio Inc (MBIO) Stock Quote, History and News - Yahoo Finance
Mustang Bio Inc (MBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!